Biocept Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
9,233.20
15,866.00
16,949.50
18,399.30
21,613.70
24,571.60
Depreciation, Depletion & Amortization
266.60
251.20
261.40
322.00
575.70
800.90
Other Funds
2,166.70
3,454.90
1,463.10
1,631.60
1,242.70
614.30
Funds from Operations
6,799.90
12,160.00
15,225.00
16,445.70
19,795.30
23,156.40
Changes in Working Capital
597.60
2,445.10
70.20
748.60
144.60
801.10
Net Operating Cash Flow
6,202.40
14,605.00
15,154.80
15,697.10
19,650.70
22,355.20
Capital Expenditures
0.70
394.90
165.20
482.10
1,400.20
Sale of Fixed Assets & Businesses
-
-
-
30.70
-
Net Investing Cash Flow
0.70
394.90
165.20
451.40
1,400.20
Issuance/Reduction of Debt, Net
6,071.00
2,905.10
771.40
1,834.80
2,415.40
Net Financing Cash Flow
6,087.00
20,295.40
18,776.70
11,936.50
18,588.20
Net Change in Cash
116.10
5,295.40
3,456.70
4,212.00
2,462.70
Free Cash Flow
6,203.10
15,000.00
15,320.00
16,179.10
21,050.90
Change in Capital Stock
16.00
17,390.20
19,548.10
13,771.30
21,003.60
About Biocept
View Profile
